Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Collegium Pharmaceutical patents

List of Collegium Pharmaceutical patents

List of SSH Communications Security patents

List of Eventbrite patents

List of Hub Pen Company patents

List of electronic authentication patents

Companies in the Workflow industry

Patents where

Current Assignee

Name

is

Collegium Pharmaceutical

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10004729 Tamper-resistant pharmaceutical compositions of opioids and other drugs	Patent 10004729 was granted and assigned to Collegium Pharmaceutical on June, 2018 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	10004729	June 26, 2018
	‌ US Patent 10188644 Process of making stable abuse-deterrent oral formulations	Patent 10188644 was granted and assigned to Collegium Pharmaceutical on January, 2019 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	10188644	January 29, 2019
	‌ US Patent 9682075 Tamper-resistant pharmaceutical compositions of opioids and other drugs	Patent 9682075 was granted and assigned to Collegium Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9682075	June 20, 2017
	‌ US Patent 9248195 Abuse-deterrent pharmaceutical compositions of opioids and other drugs	Patent 9248195 was granted and assigned to Collegium Pharmaceutical on February, 2016 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9248195	February 2, 2016
	‌ US Patent 9968598 Process of making stable abuse-deterrent oral formulations	Patent 9968598 was granted and assigned to Collegium Pharmaceutical on May, 2018 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9968598	May 15, 2018
	‌ US Patent 8449909 Abuse-deterrent drug formulations	Patent 8449909 was granted and assigned to Collegium Pharmaceutical on May, 2013 by the United States Patent and Trademark Office.		Collegium Pharmaceutical		United States Patent and Trademark Office	8449909	May 28, 2013
	‌ US Patent 9737530 Process of making stable abuse-deterrent oral formulations	Patent 9737530 was granted and assigned to Collegium Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9737530	August 22, 2017
	‌ US Patent 9592200 Abuse-deterrent pharmaceutical compositions of opioids and other drugs	Patent 9592200 was granted and assigned to Collegium Pharmaceutical on March, 2017 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9592200	March 14, 2017
	‌ US Patent 8758813 Abuse-deterrent drug formulations	Patent 8758813 was granted and assigned to Collegium Pharmaceutical on June, 2014 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	8758813	June 24, 2014
	‌ US Patent 8840928 Tamper-resistant pharmaceutical compositions of opioids and other drugs	Patent 8840928 was granted and assigned to Collegium Pharmaceutical on September, 2014 by the United States Patent and Trademark Office.		Collegium Pharmaceutical		United States Patent and Trademark Office	8840928	September 23, 2014
	‌ US Patent 9044398 Abuse-deterrent pharmaceutical compositions of opiods and other drugs	Patent 9044398 was granted and assigned to Collegium Pharmaceutical on June, 2015 by the United States Patent and Trademark Office.		Collegium Pharmaceutical		United States Patent and Trademark Office	9044398	June 2, 2015
	‌ US Patent 9763883 Abuse-deterrent drug formulations	Patent 9763883 was granted and assigned to Collegium Pharmaceutical on September, 2017 by the United States Patent and Trademark Office.	Collegium Pharmaceutical	Collegium Pharmaceutical		United States Patent and Trademark Office	9763883	September 19, 2017
	‌ US Patent 8557291 Abuse-deterrent pharmaceutical compositions of opioids and other drugs			Collegium Pharmaceutical		United States Patent and Trademark Office	8557291	October 15, 2013

13 results

0 selected

13 results

0 selected